PRKAA1 and amyotrophic lateral sclerosis: Interestingly, in another ALS mouse model (Tg-TDP-43), chronic treatment with another A2AR agonist (JMF1907) significantly improved motor functions by suppressing the overactivation of AMPK-α1 in the spinal cord [155].